March 27 (Reuters) - Bausch + Lomb BLCO.TO said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, the cause of which could not immediately be known.
The company said it is recalling these lenses, which are part of its enVista platform, out of an abundance of caution, and was looking to identify a root cause.
"As much as we believe in the enVista platform, patient safety will always be our number one priority," said CEO Brent Saunders.
The company's intraocular or surgically implanted lenses are used in cataract surgery to replace the natural clouded lens in the eye.
Bausch + Lomb said there have been reports of an inflammatory reaction in some patients with these lenses, adding the patients responded quickly to treatment, with none requiring removal of the lens.
The company said it is informing eye care professionals about the impacted lots and return protocols for the product.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shailesh Kuber)
((Christy.Santhosh@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。